-
Cinda Biologicals and Xinhe Biologicals reached a strategic cooperation to jointly carry out clinical research on the combination of Sintilimab and neoantigen vaccine NEO_PLIN2101 in the treatment of tumors
Time of Update: 2021-11-15
("Xinhe Bio"), a company dedicated to creating an internationally leading AI-enabled RNA innovation Pharmaceutical’s biotechnology company jointly announced that the two parties have reached a strategic cooperation to conduct clinical research on the combination of Sintilimab injection and Neo-Bio’s personalized neoantigen vaccine NEO_PLIN2101 in the treatment of tumors .
-
The large-scale price increase of Chinese medicinal materials in this area has made it an industry consensus to improve forecasting and control capabilities
Time of Update: 2021-11-15
Under the background that the price increase of Chinese medicinal materials will be a long-term trend, the industry generally believes that Chinese medicine companies need to strengthen the monitoring of market prices to improve their control and forecasting capabilities of market conditions .
-
In the first nine months, the number of new stores in the four major domestic drugstores exceeded 1,000!
Time of Update: 2021-11-15
During the reporting period, the company built 1,300 new stores, closed 26 stores due to urban transformation and strategic location adjustments, relocated 123 stores, net added 1,151 stores, and directly-operated chain stores reached 8,356 .
-
my country's vaccine market is about to exceed 60 billion yuan, and more requirements will be placed on this industry
Time of Update: 2021-11-15
There are still a few domestic companies that can provide high-end vaccine manufacturing and filling equipment; therefore, in order to further ensure vaccine safety and Production capacity, local pharmaceutical equipment companies must continue to innovate, improve production efficiency through continuous improvement of product technology, intelligence, and automation, and ensure the safety and control of product quality in vaccine production and storage .
-
How useful is it to pull black and white banners in pharmaceutical companies?
Time of Update: 2021-11-15
We are an acquisition of a pharmaceutical company, and there must be professional management, but it only involves the change of equity .
If the product of a pharmaceutical company is not good, there is a high probability that no one will buy it .
-
PDC drugs set off a fever for research and development, and large pharmaceutical companies are competing for layout
Time of Update: 2021-11-15
Currently, there are two PDC drugs on the market worldwide, one of which is Lutathera developed by Advanced Accelerator Applications SA, a subsidiary of Novartis, and is the world's first peptide receptor radionuclide therapy (PRRT) drug .
-
Pharmaceutical companies have successively disclosed their transcripts for the first three quarters. Which company has strong R&D investment?
Time of Update: 2021-11-15
While the three quarterly reports were disclosed, the research and development expenses of various pharmaceutical companies in the first three quarters have also been exposed .
According to Hengrui Pharmaceutical’s 2021 third quarter report released on October 19, Hengrui Pharmaceutical’s R&D investment continued to increase this year.
-
The 100 billion industry chain grows up!
Time of Update: 2021-11-15
Xiamen Biopharmaceutical listed companies collectively rose in the first three quarters Previous post: Hainan issued 14 "Drug Production Licenses" (B Certificates), injecting new vitality into the development of medicine [Information Search] [Add to Favorites] [Tell a Friend] [Print This Article] [Close Window] A total of 0 similar information [View all] Related comments com/static/api/js/share.
-
Pharmacy sales of four types of drugs require nucleic acid certification within 48 hours
Time of Update: 2021-11-15
In addition to requiring customers to provide nucleic acid negative certificates, pharmacies must also register detailed drug purchase information, including: name, gender, age, personal ID number, home address, body temperature, mobile phone number, and specific origin (local, returning from abroad) , The name, quantity, date of purchase and other information of the purchased drug .
-
Detailed rules for supporting traditional Chinese medicine formula particles have been issued in many places, and pharmaceutical companies will welcome new opportunities
Time of Update: 2021-11-15
In this context, manufacturers need to fulfill the main responsibility and related obligations of the whole life cycle of drugs in the future, strengthen management and control in the production and management process, and ensure the quality and safety of traditional Chinese medicine formula particles in order to better assist the industry.
-
Liaoning issued a document: 169 drugs were "stopped" procurement without review
Time of Update: 2021-11-15
According to the research of relevant securities companies, the national sales of iohexol injection will be about 4 billion yuan in 2020; another example is the new generation of proton pump inhibitor (PPI) esomeprazole sodium.
-
Voriconazole for injection by Puli Pharmaceuticals obtains marketing approval from the Ministry of Health of Costa Rica
Time of Update: 2021-11-15
On October 31, Puli Pharmaceuticals issued an announcement stating that the company had recently received a marketing permit for 200 mg of voriconazole for injection issued by the Ministry of Health of Costa Rica .
-
After investing huge sums of money, some pharmaceutical companies began to experience "dyspepsia"
Time of Update: 2021-11-15
In fact, due to the difficulty, time-consuming, labor-intensive, and costly research and development of new drugs, many pharmaceutical companies have been vigorously making new investment arrangements in order to increase corporate operating profits in recent years .
-
"Going Global" embraces a broader market, and pharmaceutical companies have made new progress in their internationalization
Time of Update: 2021-11-15
In recent years, China's pharmaceutical industry has ushered in a golden period of development, and companies have begun to "go global" and participate in international competition .
-
The scale of the biopharmaceutical market continues to expand, and the demand for related equipment continues to grow
Time of Update: 2021-11-15
Therefore, in this context, the industry believes that while domestic pharmaceutical equipment companies see opportunities, they also need to continuously increase R&D investment to accelerate the breaking of import monopoly, realize the substitution of imported products, and help China's biopharmaceutical industry to become more Good development .
-
To strictly control the quality and safety of drugs, pharmaceutical equipment needs to continue to exert efforts in two aspects
Time of Update: 2021-11-15
However, compared with large foreign pharmaceutical companies, the overall technical equipment level of domestic pharmaceutical companies is generally relatively low, especially in the high-end field; in addition, the dependence of drugs on people in the production process is still relatively high, which makes the drugs produced The quality also varies .
-
MVC-COV1901, a high-end vaccine, was selected for the WHO New Coronary Pneumonia Solidarity Test Vaccine
Time of Update: 2021-11-15
Taipei, October 28, 2021/PRNewswire/ - The vaccine candidate MVC-COV1901 of Medigen Vaccine Biologics Corp ("High-end Vaccine") was recommended by an independent vaccine priority advisory group to be included in the world The Solidarity Vaccine Trial (STv) of the World Health Organization (WHO) .
-
Financial fraud, market manipulation, and bribery of these pharmaceutical company bosses have beaten the cards in their hands.
Time of Update: 2021-11-15
Whether it is Ma Xingtian of Kangmei or Zhang Meihua of Tongjitang, whether it is Liu Qun of Tiansheng Pharmaceuticals or Liu Lingan of Hansen Pharmaceuticals, they have relied on their personal vision and courage to start their own businesses, and they have put their companies on the capital market and rewritten their lives.
-
Anti-gout drugs are coming together, and the market for over 3 billion is about to start!
Time of Update: 2021-11-15
At present, in the face of the huge anti-gout drug market, major domestic pharmaceutical companies are deploying one after another, including the development of new anti-gout drugs through independent research and development or introduction .
-
Pharmacists in pharmacies can be evaluated
Time of Update: 2021-11-15
3. Obtain a bachelor's degree in pharmacy, Chinese pharmacy or related majors or graduate from the preparatory technician (technician) class of technical colleges and universities, obtain the title of pharmacist (Chinese pharmacist), and have been employed for more than 4 years .
